HUG climbs sharply in Newsweek's 2026 global rankings

Switzerland Launches National AI Initiative for Personalized Cancer Care

Personalized care for patients with EGFR-mutant nonsmall cell lung cancer: Navigating early to advanced disease management

Blood cancers: predicting the success of cell transplants

Geneva Homologous Recombination Deficiency Test Is Predictive of Survival Benefit From Olaparib and Bevacizumab Maintenance in Ovarian Cancer

Overall survival of recurrent/metastatic head & neck squamous cell carcinoma patients progressing after ≥ 1 line of systemic therapy, treated with MVX‑ONCO‑1, a novel, first in class cell encapsulation‑based immunotherapy: results of SAKK 11/16, a phase IIa trial

First-line MET tyrosine kinase inhibitors versus immunotherapy ± chemotherapy for patients with MET exon 14 skipping mutant metastatic NSCLC

Randomized trial of relevance of time-of-day of immunochemotherapy for progression-free and overall survival in patients with non-small cell lung cancer